5 completed. 2 Phase 1, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow CB-183,315: new trials by email Literature Review of CB-183,315 trials Research Report on CB-183,315
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005) Surotomycin, Vancomycin, Placebo - Clostridium Difficile Infection | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 606 | 2012-05-16 | 2019-07-23 |
| A Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006) CB-183,315, Vancomycin, Placebo - Clostridium Difficile Infection | Phase 3 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 608 | 2012-05-16 | 2022-08-22 |
| Study of CB-183,315 in Participants With Clostridium Difficile Infection CB-183,315, Placebo, Vancomycin - Clostridium Difficile Infection, Diarrhea | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 210 | 2010-04-01 | 2018-09-11 |
| A Study of Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009) Surotomycin, Placebo - Clostridium Difficile Associated Diarrhea (CDAD) | Phase 1 | Completed | Merck Sharp & Dohme LLC | 30 | 2009-07-01 | 2016-07-22 |
| A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008) Surotomycin, Placebo - Clostridium Difficile Associated Diarrhea (CDAD) | Phase 1 | Completed | Merck Sharp & Dohme LLC | 40 | 2009-01-01 | 2016-07-22 |
Clostridium Infections (3) · Diarrhea (3)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (3) · Merck Sharp & Dohme LLC (2)
Canada (1) · United States (1)
PMID 28347318, PMID 32747931, PMID 27432604, PMID 28480267, PMID 28961905